|Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis|
M Drolet, É Bénard, MC Boily, H Ali, L Baandrup, H Bauer, S Beddows, ...
The Lancet infectious diseases 15 (5), 565-580, 2015
|Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis|
M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ...
The Lancet 394 (10197), 497-509, 2019
|Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study|
K Kavanagh, KG Pollock, K Cuschieri, T Palmer, RL Cameron, C Watt, ...
The Lancet infectious diseases 17 (12), 1293-1302, 2017
|Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types|
K Kavanagh, KGJ Pollock, A Potts, J Love, K Cuschieri, H Cubie, ...
British journal of cancer 110 (11), 2804-2811, 2014
|Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study|
T Palmer, L Wallace, KG Pollock, K Cuschieri, C Robertson, K Kavanagh, ...
bmj 365, 2019
|Reduction of low-and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland|
KGJ Pollock, K Kavanagh, A Potts, J Love, K Cuschieri, H Cubie, ...
British journal of cancer 111 (9), 1824-1830, 2014
|Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013|
RL Cameron, K Kavanagh, J Pan, J Love, K Cuschieri, C Robertson, ...
Emerging infectious diseases 22 (1), 56, 2016
|Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes|
D Mesher, K Soldan, M Lehtinen, S Beddows, M Brisson, JML Brotherton, ...
Emerging infectious diseases 22 (10), 1732, 2016
|Achieving high and equitable coverage of adolescent HPV vaccine in Scotland|
K Sinka, K Kavanagh, R Gordon, J Love, A Potts, M Donaghy, ...
J Epidemiol Community Health 68 (1), 57-63, 2014
|The burden of HPV-associated anogenital cancers|
K Wakeham, K Kavanagh
Current oncology reports 16 (9), 1-11, 2014
|Nasal swab screening for methicillin-resistant Staphylococcus aureus—how well does it perform? A cross-sectional study|
A Matheson, P Christie, T Stari, K Kavanagh, IM Gould, R Masterton, ...
Infection Control & Hospital Epidemiology 33 (8), 803-808, 2012
|HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study|
TJ Palmer, M McFadden, KGJ Pollock, K Kavanagh, K Cuschieri, ...
British Journal of Cancer 114 (5), 582-589, 2016
|Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial|
B Guthrie, K Kavanagh, C Robertson, K Barnett, S Treweek, D Petrie, ...
bmj 354, 2016
|HPV status and favourable outcome in vulvar squamous cancer|
K Wakeham, K Kavanagh, K Cuschieri, D Millan, KG Pollock, S Bell, ...
International journal of cancer 140 (5), 1134-1146, 2017
|Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study|
K Kavanagh, LA Wallace, C Robertson, P Wilson, A Scoular
International journal of epidemiology 42 (2), 493-503, 2013
|Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010|
AJ Elliot, N Singh, P Loveridge, S Harcourt, S Smith, R Pnaiser, ...
Eurosurveillance 15 (23), 19583, 2010
|Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact|
K Kavanagh, K Sinka, K Cuschieri, J Love, A Potts, KGJ Pollock, H Cubie, ...
BMC infectious diseases 13 (1), 1-8, 2013
|Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis|
K Cuschieri, K Kavanagh, C Moore, R Bhatia, J Love, KG Pollock
British journal of cancer 114 (11), 1261-1264, 2016
|Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009|
CR Simpson, NI Lone, K Kavanagh, LD Ritchie, C Robertson, A Sheikh, ...
Eurosurveillance 20 (8), 21043, 2015
|Use of HPV testing for cervical screening in vaccinated women—insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study|
R Bhatia, K Kavanagh, HA Cubie, I Serrano, H Wennington, M Hopkins, ...
International journal of cancer 138 (12), 2922-2931, 2016